Transfusion-associated Anaplasma phagocytophilum infection in a pregnant patient with thalassemia trait: a case report.

TitleTransfusion-associated Anaplasma phagocytophilum infection in a pregnant patient with thalassemia trait: a case report.
Publication TypeJournal Article
Year of Publication2015
AuthorsShields K, Cumming M, Rios J, Wong M, Zwicker J, Stramer S, Alonso C
Pagination719 - 725
Date Published2015
ISBN Number0041-1132
Other Numberswdn, 0417360
KeywordsAnaplasma phagocytophilum, pregnant, thalassemia trait, transfusion

BACKGROUND: Human granulocytic anaplasmosis (HGA) is an acute nonspecific febrile illness caused by the bacterium Anaplasma phagocytophilum. Although usually transmitted via tick bite, HGA may rarely also be acquired through transfusion. HGA during pregnancy may pose significant gestational risks due to altered maternal immune status and the potential for perinatal transmission., CASE REPORT: A pregnant 34-year-old Massachusetts woman with [beta]-thalassemia trait was diagnosed at 32 weeks of gestation with transfusion-associated HGA (TAHGA) after receiving nine leukoreduced red blood cell transfusions. She was successfully treated with rifampin therapy and gave birth to a healthy child who tested negative for HGA after delivery. An implicated blood donor was subsequently identified through physician collaboration with the regional American Red Cross and Massachusetts Department of Public Health., DISCUSSION: This is the 11th reported case of HGA in pregnancy and is at least the sixth known case in which leukoreduction did not prevent TAHGA. As seen in this case, nonspecific symptomatology of variable onset can impede diagnosis and treatment. This may increase risk of poor outcomes in maternal HGA patients. Cases of TAHGA, although currently uncommon, may increase as the incidence of HGA in certain parts of the country increases., CONCLUSION: Heightened cross-institutional awareness of the potential risk of TAHGA is warranted. Clinicians need to consider transfusion-associated infections when fever occurs in a transfusion recipient. This case provides additional evidence that leukoreduction does not obviate risk of A. phagocytophilum contamination of donated blood components., (C) 2015 John Wiley & Sons, Ltd

Notify Library Reference ID4369

Related Incidents